Sensitivity to anti-BRAF therapy: lost in translation
- PMID: 25220342
- DOI: 10.1111/pcmr.12314
Sensitivity to anti-BRAF therapy: lost in translation
Comment on
-
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.Nature. 2014 Sep 4;513(7516):105-9. doi: 10.1038/nature13572. Epub 2014 Jul 27. Nature. 2014. PMID: 25079330
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
